Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicity.
D003520:Cyclophosphamide / Q000031:analogs & derivatives*; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D007263:Infusions, Parenteral; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control; D008623:Mercaptoethanol / Q000031:analogs & derivatives*; D015080:Mesna / Q000008:administration & dosage*
D008623:Mercaptoethanol; D003520:Cyclophosphamide; D015080:Mesna; D007069:Ifosfamide